Delivery Order SPE2DB24D8003-SPE2DB25FJTSN
Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,896.78, is for the delivery of Trulicity 1.5 mg/0.5 ml pens to support medical operations of the U.S. Armed Forces. The contract falls under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,579.40, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This contract is not associated with a set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,274.39, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to support U.S. Armed Forces medical operations. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) vehicle awarded to Dakota Drug, Inc....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The contract, valued at $2,882.20, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,749.16, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The $1,261.34 contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, which are used to treat diabetes. This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a small disadvantaged business, to provide 0.75 mg/0.5 ml Trulicity pen injectors. The $5,293.36 contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment and supplies. This single-award Indefinite Delivery Contract (IDC) with Dakota Drug, Inc., valued at $999,999,999.00, allows the DLA to efficiently acquire a wide...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $3,287.55 and a period of performance extending through March 13, 2025. Dakota Drug, Inc. is a key supplier for the DLA's medical supply chain, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that enables...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Trulicity 1.5 mg/0.5 ml pens. The $2,505.06 contract has a performance period through July 31, 2024 and does not have a set-aside designation. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $1,906.50, is for the supply of 4.5 mg/0.5 ml Trulicity pens, a medication used to treat diabetes. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., valued at $999,999,999.00, which...
- SPE2DB24D8003Indefinite Delivery Contract
- SPE2DB24D8003-SPE2DB25FJTSNDelivery Order
This is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,003.07, is for the delivery of Trulicity 1.5 mg/0.5 ml pens to support U.S. Armed Forces medical operations. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a performance period extending through January 29, 2025 and does not utilize a set-aside designation.
Generated 7/1/25, 5:29 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/28/25 |